GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Intuitive Surgical, Inc. (ISRG) [hlAlert]

Rating:
Outperform
ISRG
down 3.86 %

Intuitive Surgical, Inc. (ISRG) upgraded to Outperform with price target $560 by Barrington Research

Posted on: Wednesday,  Oct 31, 2012  10:25 AM ET by Barrington Research

Barrington Research rated Outperform Intuitive Surgical, Inc. (NASDAQ: ISRG) on 10/31/2012, when the stock price was $536.32. Since
then, Intuitive Surgical, Inc. has lost 3.87% as of 01/22/2016's recent price of $515.57.
If you would have followed this Barrington Research's recommendation on ISRG, you would have lost 3.86% of your investment in 1178 days.

Intuitive Surgical, Inc. designs and manufactures the da Vinci Surgical System. The da Vinci Surgical System seamlessly translates the surgeon's natural hand movements on instrument controls at a console into corresponding micromovements of instruments positioned inside the patient through small puncture incisions, or ports. The products provide the surgeon with the range of motion and fine tissue control previously possible only with open surgery, while simultaneously allowing the surgeon to work through small ports.

As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2012 10:25 AM Buy
None
536.32 560.00
as of 12/31/2012
1 Week up  0.13 %
1 Month down  -7.30 %
3 Months down  -8.56 %
1 YTD down  -8.56 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/28/2009 10:25 AM Hold
None
220.79
6/19/2009 10:25 AM Buy
None
161.15 200.00
2/18/2009 10:25 AM Buy
None
106.81 175.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy